Anticancer Effects of the Organosilicon Multidrug Resistance Modulator SILA 421

E-ISSN： 1875-5992|12|6|663-671

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.12, Iss.6, 2012-07, pp. : 663-671

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fluoxetine synergys with anticancer drugs to overcome multidrug resistance in breast cancer cells

By Zhou Ting

Tumor Biology, Vol. 33, Iss. 5, 2012-10 ,pp. : 1299-1306

Springer Publishing Company

Access to resources Recommend Favorite

Targeting glucosylceramide synthase downregulates expression of the multidrug resistance gene MDR1 and sensitizes breast carcinoma cells to anticancer drugs

By Sun Yanlin

Breast Cancer Research and Treatment, Vol. 121, Iss. 3, 2010-06 ,pp. : 591-599

Springer Publishing Company

Access to resources Recommend Favorite

In Vivo Evaluation of Eclipta alba Extract as Anticancer and Multidrug Resistance Reversal Agent

By Chaudhary Harshita Jena Prasant Kumar Seshadri Sriram

Nutrition and Cancer, Vol. 66, Iss. 5, 2014-07 ,pp. : 904-913

Routledge Ltd

Access to resources Recommend Favorite

Anticancer effects of a specific mixture of nutrients in the multidrug-resistant human uterine sarcoma MES-SA/Dx5 and the drug-sensitive MES-SA cell lines

Oncology Reports, Vol. 27, Iss. 1, 2012-01 ,pp. : 17-27

Spandidos Publications

Access to resources Recommend Favorite

Differential effects of the immunosuppressive agents cyclosporin A, tacrolimus and sirolimus on drug transport by multidrug resistance proteins

By Pawarode Attaphol Shukla Suneet Minderman Hans Fricke Stacy Pinder Elaine O’Loughlin Kieran Ambudkar Suresh Baer Maria

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 2, 2007-07 ,pp. : 179-188

Springer Publishing Company

Access to resources Recommend Favorite